UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC

Cancer letters, 2018-08, Vol.428, p.117-126

2018

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer stem cells: The root of resistance

Cancer letters, 2016-03, Vol.372 (2), p.147-156

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC

Lung cancer (Amsterdam, Netherlands), 2019-09, Vol.135, p.217-227

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer

Biochimica et biophysica acta, 2010-04, Vol.1805 (2), p.153-166

2010

Link zum Volltext

Verfügbarkeit prüfen

COX-derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention

Biochimica et biophysica acta, 2012-01, Vol.1825 (1), p.49-63

2012

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines

Cellular immunology, 2017-09, Vol.319, p.35-42

2017

Link zum Volltext

Verfügbarkeit prüfen

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-06, Vol.132, p.126-131

2019

Link zum Volltext

Verfügbarkeit prüfen

The emerging role of microRNAs in resistance to lung cancer treatments

Cancer treatment reviews, 2015-02, Vol.41 (2), p.160-169

2015

Link zum Volltext

Verfügbarkeit prüfen

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer

Biochimica et biophysica acta, 2014-05, Vol.1842 (5), p.747-755

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting the fibroblast growth factor receptor family in cancer

Cancer treatment reviews, 2016-05, Vol.46, p.51-62

2016

Link zum Volltext

Verfügbarkeit prüfen

How does the Timing of Chemotherapy Affect Outcome Following Radical Surgery for Malignant Pleural Mesothelioma?

Lung cancer (Amsterdam, Netherlands), 2016-10, Vol.100, p.5-13

2016

Link zum Volltext

Verfügbarkeit prüfen

hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases

DNA repair, 2017-06, Vol.54, p.30-39

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis

Lung cancer (Amsterdam, Netherlands), 2023-03, Vol.177, p.11-20

2023

Link zum Volltext

Verfügbarkeit prüfen

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

European journal of cancer (1990), 2017-09, Vol.83, p.302-312

2017

Link zum Volltext

Verfügbarkeit prüfen

Evolution, immune response, and cancer

The Lancet (British edition), 2000-09, Vol.356 (9234), p.1033-1034

2000

Link zum Volltext

Verfügbarkeit prüfen

O-138 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S43-S43

2003

Link zum Volltext

Verfügbarkeit prüfen

62 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S288-S288

2003

Link zum Volltext

Verfügbarkeit prüfen

Infection and cancer

The Lancet (British edition), 2001-07, Vol.358 (9276), p.156-156

2001

Link zum Volltext

Verfügbarkeit prüfen

SP-325 elective cyclooxygenase (COX)-2 inhibitors in combination with cytokines induce growth arrest in non-small cell lung cancer cell lines at clinically relevant doses

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S174-S174

2003

Link zum Volltext

Verfügbarkeit prüfen

P-489 Hypoxia inducible factor-1 alpha in non-small cell lung cancer: Relation to other biological factors and prognosis

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S214-S214

2003

Link zum Volltext

Verfügbarkeit prüfen

O-78 Microarray analysis of mesothelial cells treated with crocidolite, erionite, IL-1beta and TNF-alpha

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S25-S26

2003

Link zum Volltext

Verfügbarkeit prüfen

P-479 The expression and prognostic significance of Akt and phosphorylated Akt (pAkt) in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S212-S212

2003

Link zum Volltext

Verfügbarkeit prüfen

Infection and cancer

The Lancet (British edition), 2001-07, Vol.358 (9276), p.155-155

Kallen, Ronald J

2001

Link zum Volltext

Verfügbarkeit prüfen

O-153 Results of a phase II trial of EGF-P64 vaccine in patients with

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S47-S47

2003

Link zum Volltext

Verfügbarkeit prüfen

Polycyclic aromatic hydrocarbons and their hydroxylated metabolites in fish bile and sediments from coastal waters of Colombia

Environmental pollution (1987), 2008-02, Vol.151 (3), p.452-459

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(14)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Oncology
(9)
Chemotherapy
(6)
Lung Neoplasms - Drug Therapy
(5)
Animals
(4)
Antineoplastic Agents - Therapeutic Use
(4)
Cancer
(4)
Female
(4)
Hematology, Oncology And Palliative Medicine
(4)
Lung Cancer
(4)
Male
(4)
Non-Small Cell Lung Cancer
(4)
Respiratory System
(4)
Signal Transduction
(4)
Adult
(3)
Aged
(3)
Aged, 80 And Over
(3)
Antineoplastic Agents - Pharmacology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC

Lung cancer stem cells: The root of resistance

Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC

The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer

COX-derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer

The emerging role of microRNAs in resistance to lung cancer treatments

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer

Targeting the fibroblast growth factor receptor family in cancer

How does the Timing of Chemotherapy Affect Outcome Following Radical Surgery for Malignant Pleural Mesothelioma?

hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases

Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

Evolution, immune response, and cancer

O-138 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

62 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

Infection and cancer

SP-325 elective cyclooxygenase (COX)-2 inhibitors in combination with cytokines induce growth arrest in non-small cell lung cancer cell lines at clinically relevant doses

P-489 Hypoxia inducible factor-1 alpha in non-small cell lung cancer: Relation to other biological factors and prognosis

O-78 Microarray analysis of mesothelial cells treated with crocidolite, erionite, IL-1beta and TNF-alpha

P-479 The expression and prognostic significance of Akt and phosphorylated Akt (pAkt) in non-small cell lung cancer

Infection and cancer

O-153 Results of a phase II trial of EGF-P64 vaccine in patients with

Polycyclic aromatic hydrocarbons and their hydroxylated metabolites in fish bile and sediments from coastal waters of Colombia

Aktive Filter

Suchergebnisse filtern